A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19

Nelfinavir, an orally administered inhibitor of human immunodeficiency virus protease, inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro. We conducted a randomized controlled trial to evaluate the clinical efficacy and safety of nelfinavir in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Taiga, Hosogaya, Naoki, Fukushige, Yuri, Takemori, Sachiko, Morimoto, Shinpei, Yamamoto, Hiroshi, Hori, Makoto, Ozawa, Yoshihito, Shiko, Yuki, Inaba, Yosuke, Kurokawa, Tomoya, Hanaoka, Hideki, Iwanami, Shoya, Kim, Kwangsu, Iwami, Shingo, Watashi, Koichi, Miyazawa, Ken, Umeyama, Takashi, Yamagoe, Satoshi, Miyazaki, Yoshitsugu, Wakita, Takaji, Sumiyoshi, Makoto, Hirayama, Tatsuro, Izumikawa, Koichi, Yanagihara, Katsunori, Mukae, Hiroshi, Kawasuji, Hitoshi, Yamamoto, Yoshihiro, Tarumoto, Norihito, Ishii, Hiroshi, Ohno, Hideaki, Yatera, Kazuhiro, Kakeya, Hiroshi, Kichikawa, Yoshiko, Kato, Yasuyuki, Matsumoto, Tetsuya, Saito, Makoto, Yotsuyanagi, Hiroshi, Kohno, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269734/
https://www.ncbi.nlm.nih.gov/pubmed/37140398
http://dx.doi.org/10.1128/spectrum.04311-22

Ejemplares similares

Ejemplares similares